Search

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Monday, May 17, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Larry Norton Elected to the American Academy of Arts & Sciences Larry Norton Larry Norton, MD , Senior Vice President, Office of the President; Medical Director, Evelyn H. Lauder Breast

Discovery reveals that the genetic causes of cancer may be more complicated than previously thought.

… Wednesday, May 27, 2020 Summary It turns out that finding driver mutations may be more complicated than previously thought: Nearly a quarter of all tumors have two different mutations in the same gene. A major effort in cancer research is the search for driver mutations in tumors. These mutations are

The PICI@MSK fellowship will provide Dr. Delconte with two years of financial support for her research on natural killer cells in cancer.

… Wednesday, March 17, 2021 Rebecca Delconte is a postdoctoral fellow working in the lab of immunologist Joseph Sun in the Sloan Kettering Institute. She is the recipient of the 2021-2022 Parker Institute for Cancer Immunotherapy at MSK  Postdoctoral Fellowship, which will provide two years of financial

An international team of researchers led by Sandra Misale, research associate at the Sloan Kettering Institute, examined the effects of the experimental cancer drug, AMG510, which targets KRAS G12C cell lines, and found that the efficacy of such KRAS G12C inhibitors is lineage-specific. These findings provide a mechanistic understanding of the differences in response to KRAS G12C inhibitor in lung and colorectal cancers.

… Tuesday, May 19, 2020 Background KRAS is one of the most commonly mutated genes in human tumors, including lung, colon and pancreatic cancers. Mutant KRAS has been considered undruggable for decades until the recent development of a new class of covalent inhibitors that are able to inhibit the G12C mutant

Memorial Sloan Kettering Cancer Center (MSK) has been recognized by the American College of Surgeons (ACS) for its commitment to providing optimal surgical care for children and adolescents.

… Tuesday, March 14, 2023 Memorial Sloan Kettering Cancer Center (MSK) has been recognized by the American College of Surgeons (ACS) for its commitment to providing optimal surgical care for children and adolescents. It is the first hospital in the nation to receive the ACS’ Children’s Surgery Verification

Learn how Randy Reif got state-of-the-art care for a benign brain tumor at Memorial Sloan Kettering Cancer Center.

… Wednesday, February 16, 2022 Police officer Randy Reif was trained to handle almost any situation. But nothing could have prepared him for the fight of his life. Randy woke up one day in October 2021 feeling lightheaded. He also noticed changes in his vision. Before long, Randy was on the floor, having

A team of experts at MSK shared their insights on managing blood cancer or a bone marrow transplant in a recent Information Session.

… Monday, June 15, 2020 Concerns around COVID-19 are common in the general population, but cancer patients are also balancing questions about what the pandemic means for their treatment, prognosis, and vulnerability to the virus.  A team of experts at MSK shared their insights on this topic in an Information

For clinical research stakeholders, implementing and scaling electronic source date (eSource) is a priority. With participation from MSK, a number of Society of Clinical Data Management (SCDM) working groups have collaborated on a paper outlining consensus recommendations on eSource best practices.

… Tuesday, January 13, 2026 For clinical research stakeholders, implementing and scaling electronic source date (eSource) is a priority. With participation from MSK, a number of  Society of Clinical Data Management (SCDM) working groups have collaborated on a paper outlining consensus recommendations on

Results to be presented at the upcoming American Society of Clinical Oncology (ASCO) meeting suggest combination immunotherapy may help more people with the most common form of lung cancer.

… Wednesday, June 1, 2016 Summary Immunotherapy has emerged as a promising new treatment option for people with lung cancer . MSK scientists are conducting research to enable more patients to benefit from immunotherapies, at earlier stages. We spoke with MSK lung cancer and immunotherapy expert Matthew

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.

… Tuesday, July 30, 2019 Memorial Sloan Kettering Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to  U.S. News & World Report  in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK